For instance, two acyclic sesquiterpenoid metabolites (F4 and F5) produced by C. metapsilosis M2006B have been found to significantly alleviate murine colitis through the selective activation of the farnesoid X receptor (FXR), indicating their therapeutic and prophylactic potential for IBD [163]. The gene discussed is NR1H4; the disease is colitis.